Bacteremia due to Staphylococcus aureus with reduced susceptibility to vancomycin. (Q54055447)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764969%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Bacteremia due to Staphylococcus aureus with reduced susceptibility to vancomycin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764969%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

main subject

Staphylococcus aureus

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764969%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Yuen Kwok-yung

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764969%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P C Woo

5

1 reference

ORCID Public Data File 2021

author name string

S S Wong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764969%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T K Ng

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764969%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

W C Yam

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764969%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D N Tsang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764969%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764969%20AND%20SRC:MED&resulttype=core&format=json

Diagnostic Microbiology and Infectious Disease

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764969%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764969%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764969%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

261-268

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764969%20AND%20SRC:MED&resulttype=core&format=json

In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis.

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900141-8

7 January 2021

Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900141-8

7 January 2021

Resistance of staphylococci in The Netherlands: surveillance by an electronic network during 1989-1995

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900141-8

7 January 2021

Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Düsseldorf area

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900141-8

7 January 2021

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900141-8

7 January 2021

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900141-8

7 January 2021

The assessment of antimicrobial combinations

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900141-8

7 January 2021

A Semiquantitative Culture Method for Identifying Intravenous-Catheter-Related Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900141-8

7 January 2021

First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900141-8

7 January 2021

The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900141-8

7 January 2021

The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900141-8

7 January 2021

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900141-8

7 January 2021

Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900141-8

7 January 2021

Bacteremia caused by staphylococci with inducible vancomycin heteroresistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900141-8

7 January 2021

10.1016/S0732-8893(99)00141-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764969%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference